These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17445569)

  • 1. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll like receptors and acute allograft rejection.
    Goldstein DR
    Transpl Immunol; 2006 Dec; 17(1):11-5. PubMed ID: 17157206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate alloimmunity: history and current knowledge.
    Land W
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive strategies in organ transplantation in the light of innate immunity.
    Land WG
    Exp Clin Transplant; 2006 Jun; 4(1):406-15. PubMed ID: 16827635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity in transplant tolerance and rejection.
    Murphy SP; Porrett PM; Turka LA
    Immunol Rev; 2011 May; 241(1):39-48. PubMed ID: 21488888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injury to allografts: innate immune pathways to acute and chronic rejection.
    Land WG
    Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.
    Palmer SM; Burch LH; Mir S; Smith SR; Kuo PC; Herczyk WF; Reinsmoen NL; Schwartz DA
    Clin Transplant; 2006; 20(1):30-6. PubMed ID: 16556150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference and innate immunity.
    Sioud M
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):153-63. PubMed ID: 17459518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment.
    Jiang J; Arp J; Kubelik D; Zassoko R; Liu W; Wise Y; Macaulay C; Garcia B; McFadden G; Lucas AR; Wang H
    Transplantation; 2007 Nov; 84(9):1158-67. PubMed ID: 17998872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of acute transplant rejection revisited.
    Ponticelli C
    J Nephrol; 2012; 25(2):150-8. PubMed ID: 22101676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The innate natural killer cells in transplant rejection and tolerance induction.
    Kroemer A; Edtinger K; Li XC
    Curr Opin Organ Transplant; 2008 Aug; 13(4):339-43. PubMed ID: 18685327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of innate immunity in acute allograft rejection after lung transplantation.
    Palmer SM; Burch LH; Davis RD; Herczyk WF; Howell DN; Reinsmoen NL; Schwartz DA
    Am J Respir Crit Care Med; 2003 Sep; 168(6):628-32. PubMed ID: 12773319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.